IOL Chemicals and Pharmaceuticals · NSE: IOLCP · BSE: 524164
Q4 FY19 results · Jan–Mar 2019
IOL Chemicals and Pharmaceuticals reported revenue from operations of ₹422.29 crore and net profit of ₹101.65 crore for Q4 FY19 (Jan–Mar 2019), on a standalone basis.
| Item | Q4 FY19 | Q4 FY18 | YoY | Q3 FY19 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 422.29 | — | — | 478.29 | −11.7% |
| Other income | 2.20 | — | — | 0.85 | +158.8% |
| Total income | 424.49 | — | — | 479.14 | −11.4% |
| Profit before tax | 142.52 | — | — | 115.13 | +23.8% |
| Net profit for the period | 101.65 | — | — | 82.24 | +23.6% |
| EPS, basic (₹) | 18.08 | — | — | 14.63 | +23.6% |
| Net margin (%) | 24.1 | — | 17.2 |
Standalone
- Filed with BSE
- 07 Jun 2019, 12:00 IST
- Board meeting
- 29 May 2019
- Period
- 01 Jan 2019 to 31 Mar 2019
- Review status
- Audited
- Source
- XBRL filing on BSE